P Sedlaczek

603 total citations
25 papers, 486 citations indexed

About

P Sedlaczek is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, P Sedlaczek has authored 25 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Reproductive Medicine. Recurrent topics in P Sedlaczek's work include Ovarian cancer diagnosis and treatment (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). P Sedlaczek is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). P Sedlaczek collaborates with scholars based in Poland, Germany and Sweden. P Sedlaczek's co-authors include A Harłozińska, R. Einarsson, Błażej Misiak, Lidia Karabon, Andrzej Kiejna, Dorota Frydecka, Anna Tomkiewicz, Edyta Pawlak, Jan Aleksander Beszłej and A. van Dalen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

P Sedlaczek

24 papers receiving 474 citations

Peers

P Sedlaczek
Comparison fields: 5 of 69
  • Molecular Biology 172
  • Oncology 133
  • Biological Psychiatry 118
  • Reproductive Medicine 74
  • Cancer Research 65
Replace Varda Oron‐Karni with:
Varda Oron‐Karni Israel
Isabel Ben‐Batalla Germany
Konrad Honold Germany
Cinzia Brunacci Italy
Raluca A. Budiu United States
Karen M. Palaszynski United States
J.M. Bidart France
De‐Yan Hou United States
Nicholas I. Fleming Australia
Nikola Živković Serbia
Varda Oron‐Karni Israel View profile →
Citations per field, relative to P Sedlaczek
P Sedlaczek · 1×
Citations per year, relative to P Sedlaczek
P Sedlaczek · 1×

Countries citing papers authored by P Sedlaczek

Since Specialization
Citations

This map shows the geographic impact of P Sedlaczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Sedlaczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Sedlaczek more than expected).

Fields of papers citing papers by P Sedlaczek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Sedlaczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Sedlaczek. The network helps show where P Sedlaczek may publish in the future.

Co-authorship network of co-authors of P Sedlaczek

This figure shows the co-authorship network connecting the top 25 collaborators of P Sedlaczek. A scholar is included among the top collaborators of P Sedlaczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Sedlaczek. P Sedlaczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia
6
2 26
3 116
4 34
5 28
6 9
7
[The value of the cytocins and the solubility of theirs receptors in the serum of the patients with the cervical cancer].
1
8
Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
35
9 57
10
Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias.
15
11 50
12
Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement.
16
13 8
14 2
15
TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
18
16 17
17 2
18
Gel filtration of carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA) on the Superose 12HR column: effect of guanidine hydrochloride.
1
19 18
20 14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026